Literature DB >> 32154851

Prevalence of Pathogenic Variants in Cancer Susceptibility Genes Among Women With Postmenopausal Breast Cancer.

Allison W Kurian1, Ryan Bernhisel2, Katie Larson2, Jennifer L Caswell-Jin1, Aladdin H Shadyab3, Heather Ochs-Balcom4, Marcia L Stefanick1.   

Abstract

Entities:  

Year:  2020        PMID： 32154851      PMCID： PMC7064876          DOI： 10.1001/jama.2020.0229

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  The Women's Health Initiative recruitment methods and results.

Authors:  Jennifer Hays; Julie R Hunt; F Allan Hubbell; Garnet L Anderson; Marian Limacher; Catherine Allen; Jacques E Rossouw
Journal:  Ann Epidemiol       Date:  2003-10       Impact factor: 3.797

2.  A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes.

Authors:  J M Eggington; K R Bowles; K Moyes; S Manley; L Esterling; S Sizemore; E Rosenthal; A Theisen; J Saam; C Arnell; D Pruss; J Bennett; L A Burbidge; B Roa; R J Wenstrup
Journal:  Clin Genet       Date:  2013-12-20       Impact factor: 4.438

3.  NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.

Authors:  Mary B Daly; Robert Pilarski; Michael Berry; Saundra S Buys; Meagan Farmer; Susan Friedman; Judy E Garber; Noah D Kauff; Seema Khan; Catherine Klein; Wendy Kohlmann; Allison Kurian; Jennifer K Litton; Lisa Madlensky; Sofia D Merajver; Kenneth Offit; Tuya Pal; Gwen Reiser; Kristen Mahoney Shannon; Elizabeth Swisher; Shaveta Vinayak; Nicoleta C Voian; Jeffrey N Weitzel; Myra J Wick; Georgia L Wiesner; Mary Dwyer; Susan Darlow
Journal:  J Natl Compr Canc Netw       Date:  2017-01       Impact factor: 11.908

4.  Gene-panel sequencing and the prediction of breast-cancer risk.

Authors:  Douglas F Easton; Paul D P Pharoah; Antonis C Antoniou; Marc Tischkowitz; Sean V Tavtigian; Katherine L Nathanson; Peter Devilee; Alfons Meindl; Fergus J Couch; Melissa Southey; David E Goldgar; D Gareth R Evans; Georgia Chenevix-Trench; Nazneen Rahman; Mark Robson; Susan M Domchek; William D Foulkes
Journal:  N Engl J Med       Date:  2015-05-27       Impact factor: 91.245
  4 in total
  13 in total

1.  Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer.

Authors:  Pat W Whitworth; Peter D Beitsch; Rakesh Patel; Barry Rosen; Gia Compagnoni; Paul L Baron; Rache Simmons; Eric A Brown; Linsey Gold; Dennis Holmes; Linda Ann Smith; Michael Kinney; Ian Grady; Patricia Clark; Karen Barbosa; Samuel Lyons; Lee Riley; Cynara Coomer; Lisa Curcio; Antonio Ruiz; Sadia Khan; Heather MacDonald; Kevin Hughes; Mary Kay Hardwick; Brandie Heald; Sandra B Munro; Sarah M Nielsen; Edward D Esplin
Journal:  JAMA Netw Open       Date:  2022-09-01

2.  Constitutional BRCA1 Methylation and Risk of Incident Triple-Negative Breast Cancer and High-grade Serous Ovarian Cancer.

Authors:  Per E Lønning; Oleksii Nikolaienko; Kathy Pan; Allison W Kurian; Hans P Eikesdal; Mary Pettinger; Garnet L Anderson; Ross L Prentice; Rowan T Chlebowski; Stian Knappskog
Journal:  JAMA Oncol       Date:  2022-09-08       Impact factor: 33.006

3.  Strategies to enhance identification of hereditary breast cancer gene carriers.

Authors:  Sonya Reid; Lucy B Spalluto; Tuya Pal
Journal:  Expert Rev Mol Diagn       Date:  2020-09-11       Impact factor: 5.225

4.  Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on Prognosis.

Authors:  Peter A Fasching; Siddhartha Yadav; Chunling Hu; Marius Wunderle; Lothar Häberle; Steven N Hart; Matthias Rübner; Eric C Polley; Kun Y Lee; Rohan D Gnanaolivu; Peyman Hadji; Hanna Hübner; Hans Tesch; Johannes Ettl; Friedrich Overkamp; Michael P Lux; Arif B Ekici; Bernhard Volz; Sabrina Uhrig; Diana Lüftner; Markus Wallwiener; Volkmar Müller; Erik Belleville; Michael Untch; Hans-Christian Kolberg; Matthias W Beckmann; André Reis; Arndt Hartmann; Wolfgang Janni; Pauline Wimberger; Florin-Andrei Taran; Tanja N Fehm; Diethelm Wallwiener; Sara Y Brucker; Andreas Schneeweiss; Andreas D Hartkopf; Fergus J Couch
Journal:  J Clin Oncol       Date:  2021-03-29       Impact factor: 44.544

Review 5.  CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate.

Authors:  Lenka Stolarova; Petra Kleiblova; Marketa Janatova; Jana Soukupova; Petra Zemankova; Libor Macurek; Zdenek Kleibl
Journal:  Cells       Date:  2020-12-12       Impact factor: 6.600

6.  Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic Testing.

Authors:  Elisha Hughes; Placede Tshiaba; Susanne Wagner; Thaddeus Judkins; Eric Rosenthal; Benjamin Roa; Shannon Gallagher; Stephanie Meek; Kathryn Dalton; Wade Hedegard; Carol A Adami; Danna F Grear; Susan M Domchek; Judy Garber; Johnathan M Lancaster; Jeffrey N Weitzel; Allison W Kurian; Jerry S Lanchbury; Alexander Gutin; Mark E Robson
Journal:  JCO Precis Oncol       Date:  2021-01-28

7.  Risk of Late-Onset Breast Cancer in Genetically Predisposed Women.

Authors:  Nicholas J Boddicker; Chunling Hu; Jeffrey N Weitzel; Peter Kraft; Katherine L Nathanson; David E Goldgar; Jie Na; Hongyan Huang; Rohan D Gnanaolivu; Nicole Larson; Amal Yussuf; Song Yao; Celine M Vachon; Amy Trentham-Dietz; Lauren Teras; Jack A Taylor; Christopher E Scott; Dale P Sandler; Tina Pesaran; Alpa V Patel; Julie R Palmer; Irene M Ong; Janet E Olson; Katie O'Brien; Susan Neuhausen; Elena Martinez; Huiyan Ma; Sara Lindstrom; Loic Le Marchand; Charles Kooperberg; Rachid Karam; David J Hunter; James M Hodge; Christopher Haiman; Mia M Gaudet; Chi Gao; Holly LaDuca; James V Lacey; Jill S Dolinsky; Elizabeth Chao; Brian D Carter; Elizabeth S Burnside; Kimberly A Bertrand; Leslie Bernstein; Paul W Auer; Christine Ambrosone; Siddhartha Yadav; Steven N Hart; Eric C Polley; Susan M Domchek; Fergus J Couch
Journal:  J Clin Oncol       Date:  2021-07-22       Impact factor: 50.717

8.  Genomic Diversity in Sporadic Breast Cancer in a Latin American Population.

Authors:  Lucía Brignoni; Mónica Cappetta; Valentina Colistro; Mónica Sans; Nora Artagaveytia; Carolina Bonilla; Bernardo Bertoni
Journal:  Genes (Basel)       Date:  2020-10-28       Impact factor: 4.096

Review 9.  Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older women.

Authors:  Neil Carleton; Azadeh Nasrazadani; Kristine Gade; Sushil Beriwal; Parul N Barry; Adam M Brufsky; Rohit Bhargava; Wendie A Berg; Margarita L Zuley; G J van Londen; Oscar C Marroquin; Darcy L Thull; Phuong L Mai; Emilia J Diego; Michael T Lotze; Steffi Oesterreich; Priscilla F McAuliffe; Adrian V Lee
Journal:  Lancet Healthy Longev       Date:  2022-01-05

10.  Germline and Somatic mutations in postmenopausal breast cancer patients.

Authors:  Tauana Rodrigues Nagy; Simone Maistro; Giselly Encinas; Maria Lucia Hirata Katayama; Glaucia Fernanda de Lima Pereira; Nelson Gaburo-Júnior; Lucas Augusto Moyses Franco; Ana Carolina Ribeiro Chaves de Gouvêa; Maria Del Pilar Estevez Diz; Luiz Antonio Senna Leite; Maria Aparecida Azevedo Koike Folgueira
Journal:  Clinics (Sao Paulo)       Date:  2021-07-16       Impact factor: 2.365
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.